TOKYO: Japan on Thursday authorised the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.
This makes Japan the second country to approve the drug after US regulators authorised it on Friday for emergency use against severe cases of COVID-19. “Remdesivir was approved under exceptional measures,” a health, labour and welfare ministry official said. “It was our country´s first such approval for the treatment of coronavirus patients,” the official told AFP. Prime Minister Abe said last week the government was getting ready to give a speedy green light to the experimental drug developed by US firm Gilead Sciences. The US go-ahead came after a major clinical trial showed remdesivir — originally developed to treat Ebola — shortened the time to recovery in some patients by a third. The difference in mortality rate was not statistically significant. Remdesivir, which is administered by injection, was already available to some patients who enrolled in clinical trials around the world. As for Avigan, developed by Japanese firm Fujifilm Toyama Chemical, top government spokesman Yoshihide Suga said the government “aims to approve it this month” if a clinical trial involving 100 patients proves effective.
Russia has said from the outset that it believes Ukraine was linked to the attack
The bill would give mentally competent adults who have been diagnosed with a terminal condition
Leftist opposition parties submitted a censure motion against the conservative government this week
The ministry alleged that the driver lost control and collided with barriers on the bridge
Republican Speaker Mike Johnson has held up a bill for months that would supply $60 billion in military and financial...
The results are likely to be shaped in part by economic woes driven by rampant inflation